(Q57274310)

English

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

scientific article published on 04 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

type 2 diabetes

0 references

0 references

Paul P. Glasziou

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

T M E Davis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R Ting

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J D Best

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M W Donoghoe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

P L Drury

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D R Sullivan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A J Jenkins

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R L O'Connell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

M J Whiting

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R J Simes

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Y A Kesäniemi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

V J Gebski

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R S Scott

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

A C Keech

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Fenofibrate Intervention and Event Lowering in Diabetes Study investigators

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

4 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

280-290

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

https://scigraph.springernature.com/pub.10.1007/s00125-010-1951-1

0 references

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of medical therapies on retinopathy progression in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Management of dyslipidemia in children and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Targets to retard the progression of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

How reliable is estimation of glomerular filtration rate at diagnosis of type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Composite renal endpoints: was ACCOMPLISH accomplished?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of VLDL and remnant particles on platelets

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Antiinflammatory properties of HDL.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Impact of treating the metabolic syndrome on chronic kidney disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Variation of serum creatinine, cystatin C, and creatinine clearance tests in persons with normal renal function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1951-1

21 January 2018

Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human beta-migrating very low density lipoprotein induces foam cell formation in human mesangial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21052978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-010-1951-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21052978%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57274310&oldid=2106492216"